Back to Market Feed

Product Information

CLINDAMYCIN (PEDI) 75 MG/5 ML is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1302 per ML under NDC 64980051110. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Aug 28, 2012. Its Orange Book therapeutic-equivalence code is AA.

CLINDAMYCIN (PEDI) 75 MG/5 ML

CLINDAMYCIN PALMITATE HYDROCHLORIDE
$0.1302per ML

Strength

75 mg/5mL

NDC

64980051110

Classification

Generic

Dosage Form

GRANULE, FOR SOLUTION

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA201821

FDA Approved

8/28/2012

TE Code

AA

On Market Since

9/11/2012

Pharmacological Classes

Decreased Sebaceous Gland Activity
Lincosamide Antibacterial
Lincosamides
Neuromuscular Blockade

Price Statistics

The NADAC for CLINDAMYCIN (PEDI) 75 MG/5 ML has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 69.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1302 per ML
All-time high$0.4399 (Mar 12, 2014)
All-time low$0.1274 (Jul 22, 2026)
52-week high$0.1817
52-week low$0.1274
Median price$0.2291
Average price$0.2480
Largest weekly change+49.2% (Aug 21, 2024)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+2.2%

1M

+2.2%

3M

-7.7%

6M

-4.9%

1Y

-28.4%

3Y

-19.9%

5Y

-39.2%

All

-69.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CLINDAMYCIN PALMITATE HYDROCHLORIDE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

CLINDAMYCIN HCL 150 MG CAPSULE
Generic
00904595961•Major Pharmaceuticals
$0.1048
per EA
CLINDAMYCIN HCL 150 MG CAPSULE
Generic
42571025101•Micro Labs Limited
$0.1048
per EA
CLINDAMYCIN HCL 150 MG CAPSULE
Generic
59762332801•Mylan Pharmaceuticals Inc.
$0.1048
per EA
CLINDAMYCIN HCL 150 MG CAPSULE
Generic
62135076501•Chartwell RX LLC
$0.1048
per EA
CLINDAMYCIN HCL 150 MG CAPSULE
Generic
63304069201•Sun Pharmaceutical Industries Inc.
$0.1048
per EA
CLINDAMYCIN HCL 150 MG CAPSULE
Generic
63304069205•Sun Pharmaceutical Industries Inc.
$0.1048
per EA
CLINDAMYCIN HCL 150 MG CAPSULE
Generic
65862018501•Aurobindo Pharma Limited
$0.1048
per EA
CLINDAMYCIN HCL 150 MG CAPSULE
Generic
65862018505•Aurobindo Pharma Limited
$0.1048
per EA
CLINDAMYCIN HCL 150 MG CAPSULE
Generic
68084024301•American Health Packaging
$0.1048
per EA
CLINDAMYCIN HCL 150 MG CAPSULE
Generic
68462014301•Glenmark Pharmaceuticals Inc., USA
$0.1048
per EA

Frequently asked questions

What is the NADAC price of CLINDAMYCIN (PEDI) 75 MG/5 ML?

The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN (PEDI) 75 MG/5 ML, manufactured by Rising Pharma Holdings Inc., is $0.1302 per ML (NDC 64980051110), effective Aug 19, 2026.

How has the price of CLINDAMYCIN (PEDI) 75 MG/5 ML changed over time?

Over the history we have for it, the NADAC for CLINDAMYCIN (PEDI) 75 MG/5 ML has declined 69.2%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CLINDAMYCIN (PEDI) 75 MG/5 ML?

Since Nov 28, 2013, the NADAC for CLINDAMYCIN (PEDI) 75 MG/5 ML has ranged from a low of $0.1274 (Jul 22, 2026) to a high of $0.4399 (Mar 12, 2014), with a median of $0.2291 per ML.

Are there cheaper alternatives to CLINDAMYCIN (PEDI) 75 MG/5 ML?

No other NADAC-published product currently shares the active ingredient and strength of CLINDAMYCIN (PEDI) 75 MG/5 ML in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CLINDAMYCIN (PEDI) 75 MG/5 ML?

CLINDAMYCIN (PEDI) 75 MG/5 ML (NDC 64980051110) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.